---
figid: PMC3540819__JTR2012-818204.001
figlink: /pmc/articles/PMC3540819/figure/fig1/
number: F1
caption: The main signaling pathways involved in thyroid carcinogenesis are the MAPK
  and PI3K-AKT pathway (reproduced with permission) [].
pmcid: PMC3540819
papertitle: 'New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory
  Advanced Papillary Thyroid Carcinoma: Literature Review.'
reftext: Kai-Pun Wong, et al. J Thyroid Res. 2012;2012:818204.
pmc_ranked_result_index: '64204'
pathway_score: 0.9736042
filename: JTR2012-818204.001.jpg
figtitle: Main signaling pathways involved in thyroid carcinogenesis are the MAPK
  and PI3K-AKT pathway (reproduced with permission) []
year: '2012'
organisms:
- Homo sapiens
ndex: 568eb79e-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3540819__JTR2012-818204.001.html
  '@type': Dataset
  description: The main signaling pathways involved in thyroid carcinogenesis are
    the MAPK and PI3K-AKT pathway (reproduced with permission) [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - MAPK9
  - MAPK10
  - HRAS
  - MAPK13
  - RET
  - MAPK3
  - PTEN
  - TAS2R38
  - MAPK1
  - MTOR
  - MAPK14
  - MAPK11
  - MAPK8
  - MAP2K2
  - AKT1
  - AKT2
  - MAPK12
  - KRAS
  - NRAS
  - MAP2K1
  - BRAF
  - tyrosine
  - Cancer
  - Lung cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: RET/PTC
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RET/PTC
  symbol: PTC
  source: hgnc_prev_symbol
  hgnc_symbol: TAS2R38
  entrez: '5726'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals:
- word: tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC3540819__F1
redirect_from: /figures/PMC3540819__F1
figtype: Figure
---
